July 2nd 2025, 9:11pm
The FDA approved Zegfrovy for advanced non-small cell lung cancer with EGFR exon 20 mutations after chemotherapy.
July 2nd 2025, 9:00pm
In part 4, the author reflects on her mother’s silent strength and unwavering love during her cancer journey, as she cared for her daughter while silently battling her own illness.
July 2nd 2025, 7:00pm
Mark Daniels, 83, says CAR T-cell therapy and strong support helped him overcome lymphoma twice and return to the fitness-focused life he values.
July 2nd 2025, 6:00pm
Tamron Little was diagnosed with peritoneal mesothelioma in 2007 as a 21-year-old new mother. Catch up on Tamron's blogs here!
July 2nd 2025, 4:32pm
The FDA approved Lynozyfic for relapsed multiple myeloma, but serious risks require restricted use under a special safety program.
July 2nd 2025, 4:00pm
Valarie Traynham, a cancer thriver and patient advocate, imparts advice and discusses survivorship after a cancer diagnosis.
July 2nd 2025, 3:00pm
Two glioblastoma patients treated with Temferon have lived 3 years post-surgery; one had no progression, the other stabilized after initial progression.
July 2nd 2025, 1:00pm
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
July 1st 2025, 9:00pm
In part 3 of “This Wasn’t the Plan,” a young woman reflects on her father’s strength during his illness and how, after her own diagnosis, their bond became her greatest source of courage.
July 1st 2025, 8:00pm
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Understanding Your Diagnosis: Stage 2 Oral Cavity Cancer
Understanding Your Diagnosis of Bile Duct Cancer
Understanding Your Stage 2 Uterine (Endometrial) Cancer
Top Blood Cancer Stories from October: Key Updates for Patients